RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,875 | -63.1% | 132,922 | -6.2% | 0.00% | – |
| Q3 2022 | $62,000 | -79.3% | 141,780 | -59.8% | 0.00% | – |
| Q2 2022 | $300,000 | -81.1% | 352,810 | +22.3% | 0.00% | – |
| Q1 2022 | $1,590,000 | +169.9% | 288,529 | +374.2% | 0.00% | – |
| Q4 2021 | $589,000 | +72.7% | 60,843 | +219.4% | 0.00% | – |
| Q3 2021 | $341,000 | -36.7% | 19,049 | -73.2% | 0.00% | – |
| Q4 2020 | $539,000 | +29.3% | 70,955 | -14.8% | 0.00% | – |
| Q3 2020 | $417,000 | +106.4% | 83,289 | +147.1% | 0.00% | – |
| Q2 2020 | $202,000 | -67.7% | 33,702 | -76.0% | 0.00% | – |
| Q1 2020 | $625,000 | -65.9% | 140,403 | -27.2% | 0.00% | -100.0% |
| Q4 2019 | $1,832,000 | -12.4% | 192,865 | -27.6% | 0.00% | 0.0% |
| Q3 2019 | $2,092,000 | -38.1% | 266,461 | +24.0% | 0.00% | -50.0% |
| Q2 2019 | $3,381,000 | – | 214,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
| Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
| Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
| HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
| Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
| Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
| Caption Management, LLC | 86,000 | $652,000 | 0.02% |
| Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |